More jobs! CARB-X also has openings

Dear All:

Building on my recent note about a search for the G20 secretariat lead, we now have CARB-X getting into job creation mode by posting 8 positions across 5 different job openings:

  • Accelerator Lead: coordinates the work of the growing accelerator network for all CARB-X-funded companies.
  • Support Team Lead (three positions): takes responsibility for managing the full range of support capabilities for 10-15 biotech and pharma companies in the Powered by CARB-X portfolio.
  • Director of Finance and Compliance: coordinates multiple partners and sub-grant recipients to ensure financial operations are in line with plans, plays a critical role in budget forecasting and planning processes, and more.
  • Project Manager: plays a critical role in the planning and execution of the funding cycles and coordination of pre-award and post-award activities.
  • Cycle Lead (two positions): takes full ownership of $20-50M funding Cycles from the preparatory stages through the three step application process, leading to the selection of a dozen or more additional companies for milestone-based awards.

As you hopefully already know, CARB-X began mid-2016 to award more than $455 million for research over a five-year period. I recently wrote about their search for new accelerators and it is good to see this continued expansion of their team. As one of the largest public-private research partnerships in the world. CARB-X is building an extraordinary pipeline of AMR-focused projects. If one of these opportunities intrigues, please check out the complete job postings online.

All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: http://amr.solutions/blog/

Upcoming meetings of interest to the AMR community:

Share

A Nature Article, a PASTEUR Act Op-Ed, and a VERY Important Phone Number

Dear All, First, Nature published an excellent article entitled “The importance of antimicrobial resistance in medical mycology” by Gow et al. The first sentence of the introduction really packs a punch — “The age of antibiotics, spanning only 80 years, is now entering a period of progressive and widespread emergence of drug-resistant organisms that threaten to bring

Raising awareness of AMR: WHO report on best approaches

Dear All, In addition to forming the inaugural WHO Task Force of AMR Survivors, the WHO has also recently released a report entitled “Awareness-raising on Antimicrobial Resistance: Report of global consultation meetings.”  The report is based on discussions at two meetings held by WHO with stakeholders from across the world. Even before opening the report,

Support the FORWARD and PASTEUR Acts by signing a letter!

Dear All, I’ve written before about the FORWARD Act, a bill introduced last year into Congress with the goal of supporting research in to treatment of endemic fungal diseases with a particular focus on coccidioidomycosis (*). It’s easy to see how this bill and the PASTEUR Act are mutually supportive … both seek to build

Scroll to Top